Nuvo Research
Manufacturing · Canada · 51-200 Employees
View Company Info for Free
Overview
Headquarters
6733 Mississauga Rd Ste 610, Mississauga...Phone Number
(732) 382-6085Website
www.nuvopharmaceuticals.comRevenue
$68.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nuvo Research
Nuvo, founded in 1983 (TSX: NRI;OTCQX: NRIFF), is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company's products target several therapeutic areas, including pain, allergy and dermatology. The Company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. Nuvo's head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and its manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration.Explore more
Nuvo Research Org Chart
Get the full picture
Sign in to uncover key details.
MV
Manager, Human Resources
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nuvo Research your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Nuvo Research, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Nuvo Research recently announced quarterly report
Click to see if Nuvo Research had a recent Job posting/layoffs
Check if Nuvo Research has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Nuvo Research
Funding: Get notified immidiatlly once Nuvo Research has new funding data
Product Launch: Get notified when Nuvo Research launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Nuvo Research is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Nuvo Research
Compare insights from companies similar to Nuvo Research, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nuvo Research is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nuvo Research is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nuvo Research.
Nuvo Research financials insights
Gather financial insights about Nuvo Research, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Debt
$6M
Nuvo Research Tech Stack
A closer look at the technologies used by Nuvo Research
See more technologies
Nuvo Research News & Media
Nuvo Pharmaceuticals Inc. (MRVFF) CEO Jesse Ledger on Q2 2022 Results - Earnings Call Transcript
Nuvo Pharmaceuticals Inc. (OTCQX:MRVFF) Q2 2022 Earnings Conference Call August 15, 2022 11:00 AM ET Company Participants Jesse Ledger - President and Chief Executive Officer Mary-Jane...Miravo Healthcare™ Announces First Quarter 2022 Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced its financial and operational results for the three months ended March 31, 2022. For further details on the results, please refer to Miravo’s Management, Discussion and Analysis (MD&A) and Condensed Consolidated Interim Financial StatNuvo Pharmaceuticals Inc. (MRVFF) CEO Jesse Ledger on Q4 2021 Results - Earnings Call Transcript
Start Time: 11:00 End Time: 11:25 Nuvo Pharmaceuticals Inc.Miravo Healthcare™ Announces 2021 and Fourth Quarter Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced its financial and operational results for the three months and year ended December 31, 2021. For further details on the results, please refer to Miravo’s Management, Discussion and Analysis (MD&A) and Consolidated Financial Statements
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Nuvo Research
Sign Up For FreeTo access detailed company insights
Nuvo, founded in 1983 (TSX: NRI;OTCQX: NRIFF), is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company's products target several therapeutic areas, including pain, allergy and dermatology. The Company's strategy is to in-license and acquire growth-oriented, complementary products f... Read More
